Fundraising Fox

Abel Ureta-Vidal

Investor

Venture Partner at Nina Capital

Cambridge, United Kingdom

Writes $10M – $50M checks · typically $25M

About

Abel Ureta-Vidal holds a PhD in molecular biology and immunovirology from the Pasteur Institute and has worked across life sciences and digital fields since the early 1990s, including roles at Genoscope on the human genome project and at the European Bioinformatics Institute leading comparative genomics research. He founded Eagle Genomics in 2008 and served on its executive team for 12 years, expanding the company's work from pharma and biotech into plant breeding, animal health, consumer goods, and food safety. Since 2020, he has worked in venture investment as Investment Director at CMS Ventures and Venture Partner at Nina Capital while mentoring founders and advising early-stage companies in the life sciences sector.

Experience

  1. Dassault SystèmesIndustry Business Consultant - Life Sciences in the EMEA Solution Consulting teamcurrent2025 — presentCambridge, England, United Kingdom
  2. OctiocorAdviser2025Cambridgeshire, England, United Kingdom
  3. OctiocorChief Executive Officer2023 — 2025Cambridge, England, United Kingdom
  4. OctiocorBusiness Strategy Adviser2022Cambridge, England, United Kingdom
  5. Genomic Data Infrastructure (GDI)Member of the Long Term Sustainability Board (LTSB)2023 — 2025
  6. sofi.healthNon Executive Director & Data Strategy Adviser2023 — 2025London Area, United Kingdom
  7. sofi.healthChief Data Officer & Co-Founder2020 — 2023London, England, United Kingdom
  8. Nina CapitalVenture Partner2021 — 2024Barcelona, Catalonia, Spain
  9. Nanograb (YC S23)Adviser2023 — 2024London, England, United Kingdom
  10. Nanograb (YC S23)Non Executive Director2023London Area, United Kingdom
  11. Nanograb (YC S23)Mentor2021 — 2022London Area, United Kingdom
  12. FAIRplusMember of the FAIRplus Scientific and Industry Advisory Board (SIAB)2019 — 2022
  13. ELIXIRChair of the Elixir Industry Advisory Committee (IAC)2018 — 2022Cambridge, England, United Kingdom
  14. CMS VenturesInvestment Director2020 — 2021Cambridge, England, United Kingdom
  15. Eagle Genomics Ltd.Chief Product Officer & Founder2018 — 2020Cambridge, United Kingdom
  16. Eagle Genomics Ltd.Chief Executive Officer & Founder2014 — 2018Cambridge, United Kingdom
  17. Eagle Genomics Ltd.COO and Founder2011 — 2014Cambridge, United Kingdom
  18. Eagle Genomics Ltd.CEO and Founder2008 — 2011Cambridge, United Kingdom
  19. BioIndustry AssociationMember of the BIA Genomics Advisory Committee (GAC)2017 — 2020London, England, United Kingdom
  20. European Bioinformatics Institute | EMBL-EBIProject Leader2001 — 2007Cambridge, England, United Kingdom

Education

  1. University of CambridgeMaster of Business Administration - MBA2007 — 2008
  2. Université Paris CitéPhD, Immulogy1994 — 1999
  3. Université Paris CitéMSc, Oncology1991 — 1992
  4. University of SussexBScH, Biochemistry and Molecular Genetics1990 — 1991
  5. Paris-Sud University (Paris XI)BSc, Biochemistry1986 — 1990

Skills & more

Biotechnology47Bioinformatics99R&D13Lifesciences61Genomics92Technology Transfer24Molecular Biology51Strategy24Computational Biology15Data Analysis10Informatics4Biochemistry19
+12 moreDrug DiscoveryCommercializationScienceCell BiologyPharmaceutical IndustryProteomicsGeneticsClinical DevelopmentOncologyCell CultureMentoringClinical Trials

Languages English · French · Spanish

From Abel's professional profile.

Colleagues at Nina Capital

Aline Noizet
Community Manager at Nina Capital
Anuj Patel
Venture Partner at Nina Capital
Austin Sawyer
Investor at Nina Capital
Bob Schulz
Chief Partnership Officer at Nina Capital
Ferran Marti
Associate at Nina Capital
Fiorela Kapllanaj
Analyst at Nina Capital
Giangiacomo Rocco
Venture Partner at Nina Capital
Helen Routh
Venture Partner at Nina Capital

Network5

Anuj Patel
Venture Partner at Nina Capital
Austin Sawyer
Investor at Nina Capital
Ferran Marti
Associate at Nina Capital
Giangiacomo Rocco
Venture Partner at Nina Capital
Helen Routh
Venture Partner at Nina Capital

Investors connected to Abel in public investor directories — a warm-intro map.

Frequently asked questions

Where does Abel Ureta-Vidal work?
Abel Ureta-Vidal is Venture Partner at Nina Capital.
What check size does Abel Ureta-Vidal write?
Abel Ureta-Vidal typically writes checks of $10M – $50M.

Same school

Also attended University of Cambridge852

Niko BonatsosInvestment Team at General CatalystGeorgia StevensonInvestor at Index VenturesHannah SealInvestor at Index VenturesLeah von SiemensPartner at Manta Ray VenturesAnthony PhilippakisInvestor at GV (Google Ventures)Erik NordlanderInvestor at GV (Google Ventures)

+ 846 more

Also attended Université Paris Cité52

Michèle OllierInvestor at MedicxiMaija MuntilaTalent Lead at Lifeline VenturesZach WhiteInvestment Team at 8VCCyril CollonGeneral Partner at Partech VenturesIsabelle TressonCommunications & Marketing Lead at Partech VenturesElena BattistelloAnalyst at Novartis Venture Fund

+ 46 more

Also attended University of Sussex52

Hamish GarnettAssociate at Manta Ray VenturesMolly CookeTeam Assistant at NorthzoneJackson HeddyCFO at NorthzoneGeorgia AbbottAssociate Director at Marlin Equity PartnersSimon SegarsExecutive Advisor at Black Opal VenturesMehmet AkalinExperts | Venture Partner at 212

+ 46 more

Also attended Paris-Sud University (Paris XI)21

Louis DussartVP, Europe at RTP GlobalXavier LazarusManaging Partner at ElaiaThierry LaugelManaging Partner at Kurma PartnersClement SalqueAssociate at Bioqube VenturesEric De La FortelleManaging Partner at Cathay HealthMaria Emilie Kath DanøManaging Partner at PSV Hafnium at PSV

+ 15 more

Shared employers

Also worked at Nina Capital19

Marc SubiratsGeneral Partner at Nina CapitalMarta G. ZanchiManaging Partner at Nina CapitalSebastian AnastassiouPartner at Nina CapitalYahel HalamishPartner at Nina CapitalFiorela KapllanajAnalyst at Nina CapitalJoan Miquel Marcos SallerasVisiting Analyst at Exceptional Ventures

+ 13 more

Also worked at Eagle Genomics Ltd.4

Jonathan MilnerInvestor at Cambridge Innovation CapitalRob GenieserManaging Partner at ETF PartnersAndrew MuirInvestment Director at UK Innovation & Science Seed FundCristián HernándezGeneral Partner at Zentynel Frontier Investments

Also worked at European Bioinformatics Institute | EMBL-EBI1

Elia StupkaManaging Director at Angelini Ventures

Also worked at Institut Pasteur8

Madison LenormandInvestor at DaphniPierreInvestor at Sanofi VenturesSamuel LevyCo-founding Partner at Lauxera Capital PartnersRebecca (Becky) PferdehirtPartner at Andreessen HorowitzBhavna TandonFounder at Brown FoodsWeronika SlesakFounder at Evolvere BioSciences

+ 2 more